$3.08
0.3412.41%
At Close: -
$3.00
-0.08-2.60%
After Hours: 6:41 PM EDT
15 minutes delayed
ADC Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ADC Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.25 | $-0.44 | 43.2 % |
Mar 2024 | 2024-05-06 | $-0.38 | $-0.56 | 32.1 % |
Dec 2023 | 2024-03-13 | $-0.97 | $-0.50 | -94.0 % |
Sep 2023 | 2023-11-07 | $-0.41 | $-0.63 | 34.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $17.41M | $18.93M | -8.03 % |
Mar 2024 | 2024-05-06 | $18.05M | $18.21M | -0.86 % |
Dec 2023 | 2024-03-13 | $16.79M | $15.33M | 9.52 % |
Sep 2023 | 2023-11-07 | $14.49M | $15.99M | -9.36 % |
ADC Therapeutics (ADCT) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.25, which beat the estimate of $-0.44.
The Actual Revenue was $17.4M, which missed the estimate of $18.9M.
Browse earnings estimates, EPS, and revenue on all stocks.